Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases

Cardiovascular disease remains a leading cause of mortality worldwide. Unresolved inflammation plays a critical role in cardiovascular diseases development. Specialized Pro-Resolving Mediators (SPMs), derived from long chain polyunsaturated fatty acids (LCPUFAs), enhances the host defense, by resolv...

Full description

Bibliographic Details
Main Authors:	Andrea Gila-Diaz, Gloria Herranz Carrillo, Pratibha Singh, David Ramiro-Cortijo
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Antioxidants
Subjects:	oxylipins specialized pro-resolving mediators long chain polyunsaturated fatty acids newborn premature infant cardiovascular diseases
Online Access:	https://www.mdpi.com/2076-3921/10/6/933

Similar Items

Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples
by: Laura Kutzner, et al.
Published: (2019-03-01)

African American Women with Cardiometabolic Complications of Pregnancy Have Decreased Serum Abundance of Specialized Pro-Resolving Lipid Mediators and Endocannabinoids
by: Kristal M. Maner-Smith, et al.
Published: (2022-12-01)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
by: Wheeler Torres, et al.
Published: (2023-08-01)

Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
by: Pilar Irún, et al.
Published: (2023-11-01)

PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)
by: Pedro-Antonio Regidor, et al.
Published: (2022-02-01)

Progress of specialized pro-resolving mediators in diabetic kidney disease
by: LIU Chong, LIU Yingying, GUO Zhaoan
Published: (2023-07-01)

HPLC-MS/MS Oxylipin Analysis of Plasma from Amyotrophic Lateral Sclerosis Patients
by: Mauricio Mastrogiovanni, et al.
Published: (2022-03-01)

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
by: Mariarosaria Valente, et al.
Published: (2022-07-01)

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
by: Pedro-Antonio Regidor, et al.
Published: (2020-12-01)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
by: Mervin Chávez-Castillo, et al.
Published: (2021-09-01)

Simulated Microgravity Affects Pro-Resolving Properties of Primary Human Monocytes
by: Alessandro Leuti, et al.
Published: (2024-01-01)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
by: Antonio Recchiuti, et al.
Published: (2020-09-01)

The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators
by: Paul M. Jordan, et al.
Published: (2021-11-01)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
by: Ping Yin, et al.
Published: (2018-07-01)

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
by: Nienke M. de Wit, et al.
Published: (2021-01-01)

Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
by: Margot Lavy, et al.
Published: (2021-06-01)

Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
by: Oxana Kytikova, et al.
Published: (2019-06-01)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
by: Davy Aubeux, et al.
Published: (2021-05-01)

Specialized Pro-Resolving Mediators and the Lymphatic System
by: Jamie D. Kraft, et al.
Published: (2021-03-01)

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators
by: Philipp Dahlke, et al.
Published: (2023-08-01)

CF Patients’ Airway Epithelium and Sex Contribute to Biosynthesis Defects of Pro-Resolving Lipids
by: Mickael Shum, et al.
Published: (2022-06-01)

Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators
by: Javier Perez-Hernandez, et al.
Published: (2021-11-01)

Roles of specialized pro-resolving mediators and omega-3 polyunsaturated fatty acids in periodontal inflammation and impact on oral microbiota
by: Chun-Teh Lee, et al.
Published: (2023-07-01)

The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes
by: Trond Vidar Hansen, et al.
Published: (2019-01-01)

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
by: María Paz Beyer, et al.
Published: (2023-07-01)

Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome
by: Qian Wang, et al.
Published: (2018-01-01)

Pro-Resolving Mediator Annexin A1 Regulates Intracellular Ca2+ and Mucin Secretion in Cultured Goblet Cells Suggesting a New Use in Inflammatory Conjunctival Diseases
by: Anne V. Lyngstadaas, et al.
Published: (2021-04-01)

Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders
by: Jana Ponce, et al.
Published: (2022-02-01)

The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression
by: Federica Liotti, et al.
Published: (2022-07-01)

Research progress of specific pro-resolving mediators in ocular surface diseases
by: Li-Xian He, et al.
Published: (2022-06-01)

Eicosanoids in Skin Wound Healing
by: Ken Yasukawa, et al.
Published: (2020-11-01)

The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
by: Luca Navarini, et al.
Published: (2023-04-01)

Behavioral changes in FPR2/ALX and Chemr23 receptor knockout mice are exacerbated by prenatal alcohol exposure
by: Sandra M. Mooney, et al.
Published: (2023-07-01)

Non-inflammatory Physiology of “Inflammatory” Mediators – Unalamation, a New Paradigm
by: Krishna Rao Maddipati
Published: (2020-10-01)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
by: Ana Beatriz Sousa, et al.
Published: (2023-04-01)

A Retrospective Study of Predictors of Mortality in Low Birth Weight Neonates in a District Hospital of Lucknow, India
by: Neha Thakur, et al.
Published: (2022-03-01)

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19
by: Maria G. Balta, et al.
Published: (2021-02-01)

RvD1<sub>n-3 DPA</sub> Downregulates the Transcription of Pro-Inflammatory Genes in Oral Epithelial Cells and Reverses Nuclear Translocation of Transcription Factor p65 after TNF-α Stimulation
by: Maria G. Balta, et al.
Published: (2022-11-01)

Maresin 1 Exerts a Tissue-Specific Regulation of Adipo-Hepato-Myokines in Diet-Induced Obese Mice and Modulates Adipokine Expression in Cultured Human Adipocytes in Basal and Inflammatory Conditions
by: Leyre Martínez-Fernández, et al.
Published: (2023-05-01)

Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners
by: Anne-Sophie Archambault, et al.
Published: (2022-01-01)